SAB Biotherapeutics (SABS) Net Shares Issued and Repurchased (2020 - 2026)
Powered by 
Analysis
SAB Biotherapeutics (SABS) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | SAB Biotherapeutics | 296.28 Mn | 296.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 18.64 Mn |
| Dec 31, 2025 | 18.19 Mn |
| Mar 31, 2025 | 11,895.00 |
| Dec 31, 2024 | 2.43 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 376,174.00 |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Mar 31, 2022 | 487,433.00 |
| Dec 31, 2021 | 1.35 Mn |
| Dec 31, 2020 | 962,088.00 |